ArticleBriefings in bioinformatics2025
MultiPep-DLCL: recognition of multifunctional therapeutic peptides through deep learning with label-sequence contrastive learning.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- SA-MTP: a structure-aware framework for multifunctional therapeutic peptide annotation.Briefings in bioinformatics · 2026Article
- Graph-Contrastive Convolutional Neural Network for Extracting and Classifying Peptide-Based Periodontal Immunomodulatory and Anti-Inflammatory Signatures.International dental journal · 2026Article
- METFAN: Multisource Enhanced Therapeutic Peptide Function Prediction via Adapter Network.ACS omega · 2025Article
- VF-Fuse: a dual-path feature fusion and iterative update architecture for virulence factor prediction.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Identifying multifunctional therapeutic peptides (MFTP) is an important yet complex challenge in the realm of peptide recognition. Unlike monofunctional peptides, MFTP classification requires discerning fine-grained labeling information associated with amino acids, making it more intricate. Existing methods often ignore the nuanced semantics of these labels and fail to fully explore the interplay between peptide sequences and their labels. To address these issues, we propose a multilabel classification method named MultiPep-DLCL. This method uses a deep learning-based model architecture to translate peptide sequences into sequence features by learning the local and global dependencies of multifunctional therapeutic peptide sequences. Additionally, the Label-Sequence Fusion Transformer is employed to efficiently learn high-quality label embeddings by mining effective information from peptide sequences. Finally, the correspondence between sequence features and label embeddings is strengthened through label-sequence contrastive learning. To tackle dataset imbalance, MultiPep-DLCL integrates a multilabel focal dice loss function alongside the traditional cross-entropy loss function. Experimental results demonstrate that the MultiPep-DLCL significantly outperforms existing methods in MFTP recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.